Gene insertion startup Tome Biosciences stops lab work as CEO shifts focus to deal talks

Tome Biosciences, a high-profile gene editing startup spun out of MIT, is halting its lab work and looking to sell itself or find a partner …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

AstraZeneca pours $135M into boosting biologics capacity in Sweden

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 28, 2024

Staffing Firm Can’t Pay Its Doctors

Staffing firm NES Health told emergency physicians that it doesn’t have enough money to pay them this month, sources told MedPage Today. The company sent

November 2, 2024

TDR’s Top 5 Psychedelic Developments For The Week Of December 11

Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of December 11. Aside from presenting a synopsis of events, we provide

December 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.